Smurf1-IN-A01

CAS No. 1007647-73-5

Smurf1-IN-A01 ( A01 )

Catalog No. M23212 CAS No. 1007647-73-5

Smurf1-IN-A01 is a ubiquitin ligase Smad ubiquitination regulatory factor-1 inhibitor (kd: 3.664 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 In Stock
5MG 65 In Stock
10MG 110 In Stock
25MG 222 In Stock
50MG 356 In Stock
100MG 530 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Smurf1-IN-A01
  • Note
    Research use only, not for human use.
  • Brief Description
    Smurf1-IN-A01 is a ubiquitin ligase Smad ubiquitination regulatory factor-1 inhibitor (kd: 3.664 nM).
  • Description
    Smurf1-IN-A01 is a ubiquitin ligase Smad ubiquitination regulatory factor-1 inhibitor (kd: 3.664 nM). It increases BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation.
  • Synonyms
    A01
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Smurf1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1007647-73-5
  • Formula Weight
    512.9
  • Molecular Formula
    C22H20ClF3N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:62.5 mg/mL (121.85 mM; Need ultrasonic)
  • SMILES
    CC1=CC=NN1C2=CC=C(C=C2)C(=O)N3CCN(CC3)S(=O)(=O)C4=CC(=C(C=C4)Cl)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cao Y, et al. Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation. Sci Rep. 2014 May 14;4:4965.
molnova catalog
related products
  • 3-(2-Glucosyloxy-4-m...

    2-O-beta-d-Glucosyloxy-4-methoxybenzenepropanoic acid[3-(2-Glucosyloxy-4-methoxyphenyl)propanoic acid] exhibits glutathione S-transferase (GST) inhibitory and antifungal activities.

  • Betulinaldehyde

    Betulinaldehyde has the inhibition of Saccharomyces sp and alpha-glucosidase.

  • Visnagin

    Visnagin has acute hypotensive anti-inflammatory and neuroprotective effects it protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.